Collection's Items (Sorted by Submit Date in Descending order): 41 to 60 of 630
| Date | Title | Author(s) |
| 21-Jan-2021 | A Design-Around Solution for a MMX-Based Tablet Drug Comprising Mesalazine—A Lesson from Shire Development, LLC v. Watson Pharmaceuticals, Inc. | 陳秉訓; Chen, Ping-Hsun |
| 21-Jan-2021 | 由企業創新管理觀點探討研究機構之技術移轉與新產品開發管理 | 吳豐祥; Wu, Feng-Shang; 胡欣怡; Hu, Hsin-Yi; 張午靈; 傅如彬 |
| 21-Jan-2021 | 台灣學術創業之發展與挑戰：科技基本法之省思與期許 | 吳豐祥; Wu, Feng-Shang; 胡欣怡; Hu, Hsin-Yi |
| 22-Jun-2020 | 英國創意產業中介組織之中介行為 | 張瑜倩; Chang, Yu-Chien |
| 22-Jun-2020 | Creating value through the performing arts festival: A multi-stakeholder approach | 張瑜倩; Chang, Yu-Chien |
| 26-May-2020 | 無用之用：新創設計公司的資源拼湊 | 吳思華; Wu, Se-Hwa; 樊學良; Fan, Hsueh-Liang; 陳意文; Chen, Yi-Wen |
| 27-Apr-2020 | The Impact of Technological Innovation upon - Evidence from Taiwan Community Innovation Survey | 許牧彥; Hsu, Mu-Yen; Hwang, Bang-Ning |
| 17-Apr-2020 | When Open Source Software Encounters Patents: Blockchain as an Example to Explore the Dilemma and Solutions | 宋皇志; SUNG, HUANG-CHIH |
| 2-Mar-2020 | Patent Eligibility Standard for Network Architecture Patents under the Federal Circuit’s Jurisprudence | 陳秉訓; Chen, Ping-Hsun |
| 2-Mar-2020 | 醫藥用途請求項及其專利有效性爭議─以明確性為中心 | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | Comeback of the Failed Entrepreneur: An Integrated View of Costs, Learning, and Residual Resources Associated with Entrepreneurial Failure | 鄭至甫; Jeng, Don Jyh-Fu; Hung, Ta Huy |
| 25-Dec-2019 | 論不當得利返還請求權做為專利侵權的不當補償手段 | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | 電視購物頻道之節目製播與商標侵權之避免─以文字的使用為例 | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | 從電視節目之商標性質論其著作權侵害與損害賠償計算 | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | 以猜歌遊戲侵害音樂著作之公開演出權 | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | 中草藥萃取物的發明人認定／智財法院102民專上23民事判決 | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | Copyright Collective Management as Compulsory Licensing in Taiwan | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | A Brand-Name Drug Company May Violate Section Two of the Sherman Act by Mislabeling a Submitted Patent in the Orange Book: An Implication from In Re Actos End-Payor Antitrust Litigation, 848 F.3d 89 (2d Cir. 2017) | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | “Plasma Concentration-Time Profile” as an Indefinite Claim Term: A Lesson from Forest Labs., Inc. v. Teva Pharm. USA, Inc. | 陳秉訓; Chen, Ping-Hsun |
| 25-Dec-2019 | Prospects and challenges posed by blockchain technology on the copyright legal system | 宋皇志; Sung, Huang-Chih |
Collection's Items (Sorted by Submit Date in Descending order): 41 to 60 of 630